Search Within

Smita Joshi

Formats
  1. Meeting Abstract (5)
  2. Journal Article (2)
  3. Review (1)
Groups
  1. Gastrointestinal Oncology Service (8)
  2. Solid Tumor Oncology Division (8)
  3. Department of Medicine (7)
  4. Survivorship Research (7)
  5. Department of Pathology and Laboratory Medicine (6)
  6. Center for Pancreatic Cancer Research (5)

More Groups

People
  1. David Ilson (5)
  2. Geoffrey Ku (5)
  3. Laura Tang (5)
  4. Steven Maron (5)
  5. Yelena Janjigian (5)
  6. Daniela Molena (3)

More People

Years
  1. 2024 (3)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (2)
Publications
  1. Journal of Clinical Oncology (4)
  2. Annals of Oncology (1)
  3. CA - A Cancer Journal for Clinicians (1)
  4. JNCI: Journal of the National Cancer Institute (1)
  5. Lancet Oncology (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. Oxford University Press (2)
  3. Elsevier Science, Inc. (1)
  4. Wiley-Blackwell (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1b/II study of durvalumab (D) and tremelimumab (T) plus PET-adjudicated chemoradiation (CRT) in patients (Pts) with esophageal adenocarcinoma
    Meeting Abstract

    Ku, G. Y.; Wu, A. J. C.; Trivedi, N.; Maron, S. B.; Joshi, S. S.; Ilson, D. H.; Janjigian, Y. Y.; Shcherba, M.; Li, J.; Tang, L. H.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Optimizing clinical research in a regional cancer center network: A survey-based approach
    Meeting Abstract

    Preeshagul, I. R.; Syldor, A.; Terzulli, S. L.; Gordon, R. A.; Evans, L. A.; Moran, S.; Eng, J.; Daly, R. M.; Rao, D.; Momtaz, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer
    Journal Article

    Lumish, M. A.; Walch, H.; Maron, S. B.; Chatila, W.; Kemel, Y.; Maio, A.; Ku, G. Y.; Ilson, D. H.; Won, E.; Li, J.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of pembrolizumab and olaparib (POLAR) maintenance for patients (pts) with metastatic pancreatic cancer (mPDAC): Two cohorts B non-core homologous recombination deficiency (HRD) and C exceptional response to platinum-therapy
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J. F.; Schwartz, C.; Varghese, A. M.; Larsen, M.; Balogun, F.; Brenner, R.; Yu, K. H.; Diguglielmo, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Regorafenib (REGO) with nivolumab (NIVO) and FOLFOX in HER2 negative esophagogastric cancer (EGC)
    Meeting Abstract

    Cytryn, S.; Joshi, S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; Rao, D.; Goldberg, Z.; Sugarman, R.; Antoine, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Current treatment and recent progress in gastric cancer
    Review

    Joshi, S. S.; Badgwell, B. D.
    CA - A Cancer Journal for Clinicians (2021)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of early-onset versus average-onset esophagogastric cancer
    Meeting Abstract

    Lumish, M. A.; Sabwa, S.; Maron, S. B.; Ku, G. Y.; Ilson, D. H.; Won, E.; Li, J.; Joshi, S. S.; Gu, P.; Strong, V. E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save